• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Imprivata Acquires Privileged Access Management Provider Xton Technologies

by Jasmine Pennic 07/08/2021 Leave a Comment

Imprivata Acquires Privileged Access Management Provider Xton Technologies

What You Should Know:

– Imprivata, the digital identity company for healthcare, today announced the acquisition of Xton Technologies, an innovative provider of privileged access management (PAM) solutions.

– Founded in 2017, Xton Technologies takes a modern approach to enterprise PAM. The company’s Xton Access Manager (XTAM) software, deployed in just hours, combines all the features of a traditional enterprise-grade solution in one platform with greatly simplified execution and at a very competitive price point. The company has been recognized as an emerging solution in the PAM market by analyst groups and industry leaders.

Acquisition Bolsters Imprivata’s Identity and Access Management Platform  

Incorporating Xton’s easy-to-deploy PAM solutions into Imprivata’s existing Identity and Access Management platform extends the company’s digital identity protection deeper into the IT organization by adding access governance for its most privileged users.

Imprivata now expands its market-leading digital identity solutions, in healthcare and beyond, by providing more solutions for Xton and Imprivata customers. Key Xton and Imprivata combined capabilities include:

– PASM (privileged account and session management) to govern and record access to highly sensitive enterprise resources such as privileged accounts, servers, and databases

– VPAM (vendor privileged access management) to monitor and control vendor and other third-party access to the enterprise, expanding the footprint of strong security

– PAM integrated with Imprivata multifactor and single sign-on solutions to bolster authentication and access control over the most highly sensitive resources

This acquisition expands the Imprivata digital identity framework and extends access control to include administrators and root users – the user type that governs critical enterprise assets such as servers, network devices, databases, and other core resources,” said Gus Malezis, CEO at Imprivata. “While our existing identity and access management solutions are designed to govern access for the clinician and other staff, this highly innovative and nimble solution set extends this reach deeper into the enterprise to safeguard and control access to an ever broader set of mission-critical resources and data.”

“The elevated focus of ransomware attacks on healthcare, and other highly regulated enterprises handling sensitive data, makes digital identity a fundamental, necessary best-practice control for improved cybersecurity, and we’re excited to make Xton a central component of Imprivata’s go-forward digital identity strategy,” said Malezis. Through this acquisition, Imprivata will enable richer authentication and access management, a key pillar in the Imprivata digital identity framework, and broaden our mutual reach to new and current customers both domestically and internationally.”

Tagged With: Healthcare Mergers & Acquisitions, Imprivata

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |